AMRN News and Press, Amarin Corporation plc From 11/25/23

2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...

-- Analysis Also Found IPE Was Associated with a 41% Reduction in Total Events Compared with Placebo -- -- Subgroup Almost Exclusively Comprised of Patients with Established Cardiovascular Disease -- -- Findings Continue to Reinforce the Scientific Data and Clinical Use of VASCE...

2023-11-01 12:30:34 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q3 2023 Earnings Call Nov 01, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript

2023-11-01 10:40:24 ET Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript November 01, 2023, 08:00 AM ET Company Participants Jordan Zwick - SVP, Business Development & IR Patrick Holt - President & CEO Tom Reilly - CFO Conference Call P...

2023-11-01 07:08:48 ET More on Amarin Amarin Corporation plc (AMRN) Cantor Fitzgerald Annual Global Healthcare Conference (Transcript) Amarin's Financial Tug-Of-War: Vascepa Vs. Generics Amarin Q3 2023 Earnings Preview Jefferies downgrades Amarin to 'hold'; s...

Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...

-- Company Reported Total Net Revenues of $66 Million in the Third Quarter 2023 -- -- Delivered Positive Cash Flow of $8 Million in the Quarter, Marking Fifth Consecutive Quarter of Cash Positive Operations 1 ; Quarter-Ending Cash Position of $321 Million -- -- Company C...

Amarin Corporation plc (AMRN) is expected to report $-0.05 for Q3 2023

2023-10-31 12:06:44 ET More on Amarin Amarin Corporation plc (AMRN) Cantor Fitzgerald Annual Global Healthcare Conference (Transcript) Amarin's Financial Tug-Of-War: Vascepa Vs. Generics Jefferies downgrades Amarin to 'hold'; shares down Amarin in deal with N...

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded research from the landmark REDUCE-IT cardiovascular outcomes trial on the effects of VASCEPA ® /VAZKEPA ® (icosapent ethyl) i...